Also known as Xopenex
Levosalbutamol (INN) or levalbuterol (USAN), trade name Xopenex, is the R-enantiomer of the short-acting β2-adrenergic receptor agonist salbutamol. It is marketed by Cipla as Levolin, & by axa named Axazest.
Source: WikipediaEstimated Total Cost: $66.97 for an average of 21 days supply
Patients are most commonly prescribed levalbuterol to treat asthma, chronic obstructive pulmonary disease (copd), wheezing, and pneumonia.
Patients taking levalbuterol most commonly experience side effects like arrhythmia, acute bronchospasm, and asthma.